Of the 48 patients with MOG-AD, 47 received testing for anti-MOG antibodies in serum, and all were positive (100%); 38 received testing for anti-MOG antibodies in CSF, and 21 were positive (43.75%). This evidence concerns the gene MOG and Alzheimer disease.